Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

[What are the special features of the treatment of venous thombo-embolic disease in the course of pregnancy and post-partum?]

Mahé I, Parent F, Sanchez O; pour le groupe de travail Recommandations de bonne pratique pour la prise en charge de la MVTE.

Rev Mal Respir. 2019 Jun 14. pii: S0761-8425(19)30178-0. doi: 10.1016/j.rmr.2019.05.012. [Epub ahead of print] French. No abstract available.

PMID:
31208886
2.

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.

Kraaijpoel N, Bleker SM, Meyer G, Mahé I, Muñoz A, Bertoletti L, Bartels-Rutten A, Beyer-Westendorf J, Porreca E, Boulon C, van Es N, Iosub DI, Couturaud F, Biosca M, Lerede T, Lacroix P, Maraveyas A, Aggarwal A, Girard P, Büller HR, Di Nisio M; UPE investigators.

J Clin Oncol. 2019 May 22:JCO1801977. doi: 10.1200/JCO.18.01977. [Epub ahead of print]

PMID:
31116676
3.

Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.

Falissard B, Picard F, Mahe I, Hanon O, Touzé E, Danchin N, Lamy FX, Ricci L, Steg PG.

Arch Cardiovasc Dis. 2019 Apr 20. pii: S1875-2136(19)30075-0. doi: 10.1016/j.acvd.2019.02.003. [Epub ahead of print]

PMID:
31014991
4.

French vascular physicians' practices in indicating antiplatelet and anticoagulation therapy in venous thromboembolism.

Fayol A, Lanéelle D, Hoffmann C, Mahé G, Mahé I.

Vasa. 2019 Jul;48(4):355-360. doi: 10.1024/0301-1526/a000789. Epub 2019 Apr 4.

5.

Perioperative management of oral anticoagulated patients undergoing an oral, implant, or periodontal procedure: a survey of practices of members of two dental scientific societies, the PRADICO study.

Radoï L, Hajage D, Giboin C, Maman L, Monnet-Corti V, Descroix V, Mahé I.

Clin Oral Investig. 2019 Mar 19. doi: 10.1007/s00784-019-02877-1. [Epub ahead of print]

PMID:
30887189
6.

[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version].

Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Feb;36(2):249-283. doi: 10.1016/j.rmr.2019.01.003. Epub 2019 Feb 22. French. No abstract available.

PMID:
30799126
7.

Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis.

Barco S, Klok FA, Mahé I, Marchena PJ, Ballaz A, Rubio CM, Adarraga MD, Mastroiacovo D, Konstantinides SV, Monreal M; RIETE Investigators.

Thromb Res. 2019 Jan;173:166-171. doi: 10.1016/j.thromres.2018.09.056. Epub 2018 Sep 27.

PMID:
30385047
8.

Protected adults' voting rights: an interdisciplinary study of medical assessment and jurisprudence in France.

Bosquet A, Mahé I.

BMJ Open. 2018 Jul 23;8(7):e020522. doi: 10.1136/bmjopen-2017-020522.

9.

Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism.

Jiménez D, Bikdeli B, Barrios D, Quezada A, Del Toro J, Vidal G, Mahé I, Quere I, Loring M, Yusen RD, Monreal M; RIETE investigators.

Int J Cardiol. 2018 Oct 15;269:327-333. doi: 10.1016/j.ijcard.2018.07.059. Epub 2018 Jul 17.

PMID:
30025658
10.

[What is the treatment duration after a venous thromboembolic event?]

Couturaud F, Mahé I.

Rev Med Interne. 2018 Nov;39(11):839-841. doi: 10.1016/j.revmed.2018.03.383. Epub 2018 May 10. French. No abstract available.

PMID:
29754698
11.

Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.

van Es N, Hisada Y, Di Nisio M, Cesarman G, Kleinjan A, Mahé I, Otten HM, Kamphuisen PW, Berckmans RJ, Büller HR, Mackman N, Nieuwland R.

Thromb Res. 2018 Jun;166:54-59. doi: 10.1016/j.thromres.2018.04.009. Epub 2018 Apr 10.

PMID:
29656167
12.

[Cancer and venous thromboembolism recurrence: The keys for an optimal management].

Mahé I, Benhamou Y, Helfer H, Chidiac J.

Bull Cancer. 2018 May;105(5):508-516. doi: 10.1016/j.bulcan.2017.12.006. Epub 2018 Mar 12. Review. French.

PMID:
29544692
13.

Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation.

Benzimra M, Bonnamour B, Duracinsky M, Lalanne C, Aubert JP, Chassany O, Aubin-Auger I, Mahé I.

Patient Prefer Adherence. 2018 Jan 4;12:79-87. doi: 10.2147/PPA.S131158. eCollection 2018.

14.

Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.

Picard F, Ducrocq G, Danchin N, Falissard B, Hanon O, Mahe I, Touzé E, Steg PG.

Arch Cardiovasc Dis. 2018 May;111(5):349-356. doi: 10.1016/j.acvd.2017.07.005. Epub 2017 Nov 27.

15.

Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.

Keita I, Aubin-Auger I, Lalanne C, Aubert JP, Chassany O, Duracinsky M, Mahé I.

Patient Prefer Adherence. 2017 Sep 25;11:1625-1634. doi: 10.2147/PPA.S131157. eCollection 2017.

16.

Prevention and treatment of cancer-associated thrombosis in France: A national survey among vascular disease and supportive care specialists.

Mahé I, Scotté F, Rey JB, Elalamy I, Lamblin A, Mayeur D, Pernod G; AFSOS (French-speaking Association for Supportive Care in Oncology), SFMV (French Society for Vascular Medicine).

J Med Vasc. 2017 Oct;42(5):255-262. doi: 10.1016/j.jdmv.2017.07.002. Epub 2017 Sep 4.

PMID:
28964384
17.

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.

van Es N, Di Nisio M, Cesarman G, Kleinjan A, Otten HM, Mahé I, Wilts IT, Twint DC, Porreca E, Arrieta O, Stépanian A, Smit K, De Tursi M, Bleker SM, Bossuyt PM, Nieuwland R, Kamphuisen PW, Büller HR.

Haematologica. 2017 Sep;102(9):1494-1501. doi: 10.3324/haematol.2017.169060. Epub 2017 May 26.

18.

Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry.

Guy JB, Bertoletti L, Magné N, Rancoule C, Mahé I, Font C, Sanz O, Martín-Antorán JM, Pace F, Vela JR, Monreal M; RIETE investigators.

Crit Rev Oncol Hematol. 2017 May;113:83-89. doi: 10.1016/j.critrevonc.2017.03.006. Epub 2017 Mar 9.

PMID:
28427527
19.

Gender differences in patients with venous thromboembolism and five common sites of cancer.

Martín-Martos F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, Lorenzo A, Barillari G, Soler S, Mahè I, Sahuquillo JC, Monreal M; RIETE Investigators.

Thromb Res. 2017 Mar;151 Suppl 1:S16-S20. doi: 10.1016/S0049-3848(17)30061-0.

PMID:
28262228
20.

Long-term treatment of cancer-associated thrombosis: the choice of the optimal anticoagulant.

Elalamy I, Mahé I, Ageno W, Meyer G.

J Thromb Haemost. 2017 May;15(5):848-857. doi: 10.1111/jth.13659. Epub 2017 Mar 21. Review.

21.

Long-term mortality in older patients discharged after acute decompensated heart failure: a prospective cohort study.

Natella PA, Le Corvoisier P, Paillaud E, Renaud B, Mahé I, Bergmann JF, Perchet H, Mottier D, Montagne O, Bastuji-Garin S.

BMC Geriatr. 2017 Jan 26;17(1):34. doi: 10.1186/s12877-017-0419-2.

22.

Renal function and venous thromboembolic diseases.

Janus N, Mahé I, Launay-Vacher V, Laroche JP, Deray G.

J Mal Vasc. 2016 Dec;41(6):389-395. doi: 10.1016/j.jmv.2016.09.001. Epub 2016 Oct 28. Review.

PMID:
28029509
23.

The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site.

Mahé I, Chidiac J, Bertoletti L, Font C, Trujillo-Santos J, Peris M, Pérez Ductor C, Nieto S, Grandone E, Monreal M; RIETE investigators.

Am J Med. 2017 Mar;130(3):337-347. doi: 10.1016/j.amjmed.2016.10.017. Epub 2016 Nov 22.

PMID:
27884650
24.

Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis.

Mahé I, Chidiac J, Helfer H, Noble S.

J Thromb Haemost. 2016 Nov;14(11):2107-2113. doi: 10.1111/jth.13483. Epub 2016 Oct 20. Review.

25.

PO-47 - Microparticles derived from ovarian cancer cell line contained genomic and biologically active proteins, including tissue factor involved in coagulation.

Besbes S, Attal R, Mirshahi S, Chidiac J, Mahé I, Pocard M, Soria J, Mirshahi M.

Thromb Res. 2016 Apr;140 Suppl 1:S194. doi: 10.1016/S0049-3848(16)30180-3. Epub 2016 Apr 8.

PMID:
27161736
26.

PO-23 - Expression of heparanase in cancer as biomarker of malignancies: overexpression in an aggressive, poor survival gastric cancer "gastric signet ring cell carcinoma" compared with that of other gastric cancers.

Fourgeaud C, Derieux S, Mirshahi S, Besbes S, Chidiac J, Mahé I, Contant G, Pocard M, Soria J, Mirshahi M.

Thromb Res. 2016 Apr;140 Suppl 1:S184-5. doi: 10.1016/S0049-3848(16)30156-6. Epub 2016 Apr 8.

PMID:
27161709
27.

Management of venous thromboembolism in cancer patients: the economic burden of hospitalizations.

Mahé I, Mayeur D, Krakowski I.

Support Care Cancer. 2016 Oct;24(10):4105-12. doi: 10.1007/s00520-016-3224-0. Epub 2016 May 4.

PMID:
27146390
28.

Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.

Mahé I, Puget H, Buzzi JC, Lamuraglia M, Chidiac J, Strukov A, Helfer H, Perozziello A.

Support Care Cancer. 2016 Aug;24(8):3369-77. doi: 10.1007/s00520-016-3164-8. Epub 2016 Mar 16.

PMID:
26984241
29.

Life-Threatening Hypercalcemia Revealing Diffuse and Isolated Acute Sarcoid-Like Myositis: A New Entity? (A Case-Series).

Mageau A, Rigolet A, Benali K, Chauchard M, Ladjeroud S, Mahe I, Maisonobe T, Chauveheid MP, Papo T, Sacre K.

Medicine (Baltimore). 2016 Mar;95(10):e3089. doi: 10.1097/MD.0000000000003089. Review.

30.

ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.

Pépin M, Kleinjan A, Hajage D, Büller HR, Di Nisio M, Kamphuisen PW, Salomon L, Veyradier A, Stepanian A, Mahé I.

J Thromb Haemost. 2016 Feb;14(2):306-15. doi: 10.1111/jth.13205. Epub 2016 Jan 25.

31.

Pulmonary embolism: Epidemiology and registries.

Monreal M, Mahé I, Bura-Riviere A, Prandoni P, Verhamme P, Brenner B, Wells PS, Di Micco P, Bertoletti L.

Presse Med. 2015 Dec;44(12 Pt 2):e377-83. doi: 10.1016/j.lpm.2015.10.006. Epub 2015 Nov 4. Review.

PMID:
26547675
32.

Additional Cost of Vte In Patients with Cancer: an Approach Based Databases.

Bourguignon S, Mayeur D, Mahe I, Krakowski I.

Value Health. 2015 Nov;18(7):A451. doi: 10.1016/j.jval.2015.09.1140. Epub 2015 Oct 20. No abstract available.

33.

[Prevention of venous thromboembolic events by fondaparinux 2.5 mg in general practice. ArchiMed Ville].

Mahé I, Daurès JP, Pouchain D, Quéré I, Aubin C, Doussaint J, Schück S, Leroyer C.

J Mal Vasc. 2015 Dec;40(6):365-75. doi: 10.1016/j.jmv.2015.06.004. Epub 2015 Jul 20. French.

PMID:
26205797
34.

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

Mahé I, Sterpu R, Bertoletti L, López-Jiménez L, Mellado Joan M, Trujillo-Santos J, Ballaz A, Hernández Blasco LM, Marchena PJ, Monreal M; RIETE Investigators.

PLoS One. 2015 Jun 15;10(6):e0128741. doi: 10.1371/journal.pone.0128741. eCollection 2015.

35.

[Prevention of venous thromboembolic events by fondaparinux 2.5mg in patients hospitalized for an acute medical illness. ArchiMed Study].

Leroyer C, Mahé I, Daurès JP, Quéré I, Aubin C, Compagnon A, Doussaint J, Schück S, Pouchain D.

J Mal Vasc. 2015 Jul;40(4):248-58. doi: 10.1016/j.jmv.2015.05.001. Epub 2015 Jun 4. French.

PMID:
26051860
36.

Conditions for exercising residents' voting rights in long-term care residences: a prospective multicenter study.

Bosquet A, El Massioui F, Mahé I.

J Aging Soc Policy. 2015;27(1):47-62. doi: 10.1080/08959420.2015.969090.

PMID:
25492566
37.

Functional status and co-morbidities are associated with in-hospital mortality among older patients with acute decompensated heart failure: a multicentre prospective cohort study.

Le Corvoisier P, Bastuji-Garin S, Renaud B, Mahé I, Bergmann JF, Perchet H, Paillaud E, Mottier D, Montagne O.

Age Ageing. 2015 Mar;44(2):225-31. doi: 10.1093/ageing/afu144. Epub 2014 Oct 12.

PMID:
25313242
38.

[A rare cause of chondritis].

Guérin C, Grasland A, Touam M, Mahé I.

Rev Med Interne. 2015 Feb;36(2):142-4. doi: 10.1016/j.revmed.2014.04.013. Epub 2014 Aug 8. French. No abstract available.

PMID:
25112805
39.

New orally active anticoagulant agents for the prevention and treatment of venous thromboembolism in cancer patients.

Gerotziafas GT, Mahé I, Elalamy I.

Ther Clin Risk Manag. 2014 Jun 13;10:423-36. doi: 10.2147/TCRM.S49063. eCollection 2014. Review.

40.

[VKA anticoagulant bridging for an invasive procedure or planned surgery: A survey of practices in general practitioners].

Bavozet F, Mahé I.

Presse Med. 2014 Jul-Aug;43(7-8):e221-31. doi: 10.1016/j.lpm.2013.12.016. Epub 2014 Apr 29. French.

PMID:
24785139
41.

[Cancer-associated venous thromboembolic recurrence: disregard of treatment recommendations].

Mahé I, Chidiac J.

Bull Cancer. 2014 Mar;101(3):295-301. doi: 10.1684/bdc.2014.1907. Review. French.

PMID:
24691192
42.

Hydroxyapatite arthropathy of the symphysis pubis.

Grasland A, Dion E, Mahé I.

J Emerg Med. 2014 May;46(5):693-4. doi: 10.1016/j.jemermed.2013.08.138. Epub 2014 Mar 4. No abstract available.

PMID:
24612631
43.

A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone.

Moreau C, Pautas E, Duverlie C, Berndt C, Andro M, Mahé I, Emmerich J, Lacut K, Le Gal G, Peyron I, Gouin-Thibault I, Golmard JL, Loriot MA, Siguret V.

Thromb Haemost. 2014 Apr 1;111(4):705-12. doi: 10.1160/TH13-07-0555. Epub 2013 Dec 12.

PMID:
24337438
44.

[Reactivation of parvovirus B19 infection in an HIV-infected woman].

Sterpu R, Ichou H, Mahé I, Mortier E.

Rev Med Interne. 2014 Jun;35(6):396-8. doi: 10.1016/j.revmed.2013.05.009. Epub 2013 Jun 20. French.

PMID:
23791089
45.

Psoriasis onset with tocilizumab.

Grasland A, Mahé E, Raynaud E, Mahé I.

Joint Bone Spine. 2013 Oct;80(5):541-2. doi: 10.1016/j.jbspin.2013.03.014. Epub 2013 Jun 2. No abstract available.

PMID:
23731639
46.

[Anticoagulant clinics in France? Which usefulness now and for the future?].

Mahé I.

Rev Med Interne. 2013 Sep;34(9):513-4. doi: 10.1016/j.revmed.2013.02.033. Epub 2013 Mar 18. French. No abstract available.

PMID:
23517772
47.

[Use of the tourniquet test in diagnosing dengue-like syndrome].

Affo C, Mortier E, Mahe E, Mahe I.

Bull Soc Pathol Exot. 2012 Dec;105(5):361-3. doi: 10.1007/s13149-012-0256-7. Epub 2012 Aug 12. French.

PMID:
22886461
48.

Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.

Grasland A, Sterpu R, Boussoukaya S, Mahe I.

Eur J Clin Pharmacol. 2012 May;68(5):895-8. doi: 10.1007/s00228-011-1191-4. Epub 2011 Dec 29. Review. No abstract available.

PMID:
22205272
49.

[Indolent deep ulcer: Buruli ulcer].

Mortier E, Grasland A, Sterpu R, Affo C, Mahé I.

Presse Med. 2012 Sep;41(9 Pt 1):892-3. doi: 10.1016/j.lpm.2011.10.018. Epub 2011 Dec 10. French. No abstract available.

PMID:
22155071
50.

[Welcome to the 64 th congress of the French National Society of Internal Medicine].

Farge-Bancel D, Lefort A, Mahé I, Algayres JP, Durant C, Roux X, Rapp C.

Rev Med Interne. 2011 Dec;32 Suppl 2:S201-2. doi: 10.1016/j.revmed.2011.09.017. Epub 2011 Nov 5. French. No abstract available.

PMID:
22056315

Supplemental Content

Support Center